Klein et al., 1982 - Google Patents
Detection and follow‐up of carcinoma of the urinary bladder by flow cytometryKlein et al., 1982
View PDF- Document ID
- 11178945492233868866
- Author
- Klein F
- Herr H
- Sogani P
- Whitmore Jr W
- Melamed M
- Publication year
- Publication venue
- Cancer
External Links
Snippet
Automated flow cytometry (FCM) has been used to study saline bladder irrigation specimens from nearly 400 patients at Memorial Sloan‐Kettering Cancer Center during the two‐year period March 1979–March 1981. These include 36 patients with papilloma, 35 with …
- 238000000684 flow cytometry 0 title abstract description 45
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Klein et al. | Detection and follow‐up of carcinoma of the urinary bladder by flow cytometry | |
Klein et al. | An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder | |
Badalament et al. | The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma | |
Maier et al. | The clinical value of urinary cytology: 12 years of experience with 615 patients. | |
Badalament et al. | The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma | |
Blomjous et al. | The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma | |
White et al. | The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer | |
Parry et al. | Cancer detection by quantitative fluorescence image analysis | |
Bard | The significance of asymptomatic microhematuria in women and its economic implications: a ten-year study | |
Renshaw et al. | Cytology of grade 1 papillary transitional cell carcinoma | |
Farsund et al. | Relation between flow cytometric DNA distribution and pathology in human bladder cancer. A report on 69 cases | |
Badalament et al. | Monitoring intravesical bacillus Calmette‐Guerin treatment of superficial bladder carcinoma by serial flow cytometry | |
Klein et al. | Flow cytometry of normal and nonneoplastic diseases of the bladder: An estimate of the false positive rate | |
Giella et al. | The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder | |
Melamed | Flow cytometry of the urinary bladder | |
CA2429526A1 (en) | Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine | |
Klein et al. | Flow cytometry followup of patients with low stage bladder tumors | |
Moran et al. | Prognostic value of nucleolar organizer regions and ploidy values in advanced colorectal cancer | |
Klein et al. | Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience | |
Bretton et al. | Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin | |
Slaton et al. | Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder | |
Highman | Transitional carcinoma of the upper urinary tract: a histological and cytopathological study. | |
Kern et al. | Cytologic evaluation of transitional cell carcinoma of the bladder | |
Hermansen et al. | Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) | |
Hermansen et al. | Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer |